soul trial oral semaglutide cardiovascular outcomes soul trial results trial: demonstrates a 14% reduction in risk of major adverse CV events SOUL (Semaglutide cardiOvascular oUtcomes triaL)
Pay in 4 interest-free payments of $5.96 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3




























